Cockcroft–Gault Equation Explained

The Cockcroft–Gault equation estimates creatinine clearance as [(140 − age) × weight in kg × (0.85 if female)] ÷ (72 × serum creatinine in mg/dL), in mL/min. Donald Cockcroft and Henry Gault published it in the journal Nephron in 1976, and it remains the most widely used bedside method for estimating renal function during drug dosing.

The Four Inputs

The equation needs only four routinely available variables. Each one shapes the result in a defined direction, which is what makes the formula transparent enough to compute by hand.

The numerator multiplies the age term by body weight, scaling the estimate to muscle mass — larger patients generate and clear more creatinine. The denominator, 72 × serum creatinine, is the marker the kidneys must remove. Choose the right body weight: ideal for normal-to-lean patients, adjusted in obesity, and actual weight when it falls below ideal. Convert units with the creatinine unit converter first if your lab reports serum creatinine in µmol/L (divide by 88.4 to reach mg/dL).

The 0.85 Female Factor

The 0.85 multiplier for female patients adjusts for lower average muscle mass, and therefore lower creatinine production, at any given serum creatinine. Without it, the equation would systematically overestimate clearance in women.

A Worked Example

Consider a 70-year-old man weighing 80 kg with a serum creatinine of 1.2 mg/dL. The numerator is (140 − 70) × 80 = 5,600; the denominator is 72 × 1.2 = 86.4. Dividing gives a creatinine clearance of about 65 mL/min. For an otherwise identical woman, applying the 0.85 factor yields roughly 55 mL/min — the same physiology, scaled for muscle mass.

History and Derivation

Cockcroft and Gault derived the formula from 249 hospitalized men, regressing measured 24-hour creatinine clearance against age, weight, and serum creatinine. The female factor was added by analogy to account for body composition. Because it predicts a timed clearance rather than a body-surface-area-indexed rate, the output is an absolute value in mL/min — the unit drug-dosing studies have used ever since. Henry Gault is the historical co-author and namesake of the equation, not a present-day reviewer of this site; the formula has stood for nearly five decades because it is simple, transparent, and tied to the dosing literature.

Choosing the Right Weight

Weight is the input most likely to change the answer, and the right choice depends on body composition. The rule of thumb is to use actual body weight when it is at or below ideal, ideal body weight for normal-to-lean patients, and adjusted body weight in obesity, because adipose tissue generates little creatinine and total body weight would overstate clearance. The ideal body weight calculator and adjusted body weight calculator produce the figures to plug in. For markedly obese patients, the purpose-built Salazar–Corcoran equation is an alternative that uses height and weight together.

How to Read the Result

The output is a creatinine clearance in mL/min, and on its own it is just a number. In practice it is read against a drug's dosing thresholds: many labels define cutoffs such as 50, 30, or 15 mL/min that trigger a dose reduction or a switch to an alternative agent. A value of about 65 mL/min reflects mild reduction; one near 30 mL/min often means a meaningful dose change; below 15 mL/min usually signals severe impairment. Always pair the number with the specific drug's renal dosing guidance rather than acting on the figure alone.

Why It Is Still the Dosing Standard

Most renal drug-dosing studies and FDA labels were validated against Cockcroft–Gault creatinine clearance, so it remains the equation of choice for renal drug dosing — even though CKD-EPI 2021 is preferred for CKD staging. Dose thresholds in package inserts (for example, “reduce the dose if CrCl < 30 mL/min”) map directly to a Cockcroft–Gault value, not to an eGFR. Using a different equation can shift a patient across a threshold and change the recommended dose. See CrCl vs eGFR for the full comparison.

Strengths and Limitations

Its strengths are simplicity, decades of dosing validation, and an absolute unit that matches drug labels. Its limitations are that it assumes a steady state, depends heavily on the weight chosen, and inherits any error in the serum creatinine measurement. It performs least well at the extremes of body size and in patients with unusual muscle mass, where creatinine generation departs from the population average.